FDA Alert
FDA Alert
07/24/2023

Jessica Ganga

Jessica Ganga
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
07/24/2023